…time. The study will assess whether NLX-112 is safe and well-tolerated by people with Parkinson’s who experience dyskinesia and whether it can reduce dyskinesia, as well as non-motor symptoms such…
Search Results "dyskinesia"
…company Newron Pharmaceuticals has signed an agreement with Zambon regarding a study to evaluate the efficacy of safinamide in people with Parkinson’s who experience levodopa-induced dyskinesia. The double-blind, placebo-controlled study,…
…but DBS is often recommended for people who meet certain requirements when medications are no longer managing OFF times effectively or there is a high occurrence of tremor, dyskinesia, or…
…significant reduction in motor fluctuations, although its beneficial effects on dyskinesia were found to be temporary and mild. Engineers at Imperial College have founded a start-up in collaboration with a…
…approximately $400 million. The acquisition will give Supernus access to the Adamas drug GOCOVRI (the only medication approved by the FDA for both OFF and dyskinesia in Parkinson’s) and Osmolex…
…to get the same motor benefits from either STN or GPi stimulation – meaning reduction/improvement in OFF time, improvement in ON time without troublesome dyskinesia, reduced dyskinesia, and improved tremor….
…and Parkinson’s Tremor and Parkinson’s: A Primer Bradykinesia and Parkinson’s: A Primer The Difference Between Dyskinesia and Tremor The Difference Between OFF and Parkinson’s Dyskinesia What Is Freezing of Gait…
…acting drug that’s used mostly to suppress dyskinesia, but also can have a mild effects on improving Parkinson’s symptoms. Does it actually cause retropulsion, that’s when you fall backwards or…
…dyskinesias from taking levodopa, and more pain. The non-motor symptoms of Parkinson’s, especially mood-related symptoms, tend to affect women to a higher degree than men. In contrast, women tend to…
During this session, we decided to go through current frustrations and see if the panel and the audience could come up with some solutions together. Watch the video and read…
…without dyskinesia (the trial’s primary endpoint). Results also demonstrated positive and clinically meaningful results for the key secondary endpoint (related to OFF time) and three additional secondary endpoints. A study…
…by Amy Montemarano Connect with our Ambassadors Additional Resources for “Hindsight is 20/20: Thoughts from an Old, Young Onset”: What Is Parkinson’s Dyskinesia? PD Movement Lab Additional Resources For “YOPD:…